Castle Biosciences, Inc. Financial Ratios — CSTL Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-39.52	7.42	-3.68	-6.94	-14.76	-12.76	3.71	-4.35
Return on Capital (%)	- -	- -	-144.3	- -	- -	- -	- -	-9.94	- -
Return on Invested Capital (%)	- -	- -	11.59	- -	- -	- -	- -	1.65	- -
Gross Margin (%)	64.21	76.75	85.91	84.54	83.18	76.64	79.53	81.87	79.37
EBITDA Margin (%)	-76.99	-15.42	14.82	-9.69	-38.98	-58.81	-25.32	7.43	-0.59
Operating Margin (%)	-79.25	-16.83	14.13	-10.44	-42.6	-66.51	-30.93	2.61	-12.44
Incremental Operating Margin (%)	- -	- -	38.39	- -	- -	- -	- -	68.26	- -
Pretax Margin (%)	-89.86	-27.9	10.31	-16.28	-42.53	-50.28	-26.1	6.49	-8.57
Profit Margin (%)	-89.93	-27.94	10.17	-16.42	-33.26	-48.99	-26.15	5.49	-7.02
Net Income to Common Margin (%)	-111	-43.64	6.02	-16.42	-33.26	-48.99	-26.15	5.49	-7.02
Effective Tax Rate (%)	- -	- -	1.35	- -	- -	- -	- -	15.39	- -
Dvd Payout Ratio (%)	18.98	35.97	-69.08	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	19	24	25	- -	8	13	15	26	37
ST Debt	1	- -	6	- -	1	2	1	2	2
LT Debt	18	24	19	- -	7	12	14	24	35
Total Debt/EBITDA	-1.76	-6.97	3.27	- -	-0.22	-0.17	-0.28	1.07	-18.1
Net Debt/EBITDA	-1.64	-5.7	-9.59	67.52	8.99	1.53	1.78	-4.45	52.32
Total Debt/EBIT	-1.71	-6.39	3.43	- -	-0.2	-0.15	-0.23	3.04	-0.86
Net Debt/EBIT	-1.6	-5.22	-10.06	62.65	8.22	1.35	1.45	-12.65	2.49
EBITDA to Interest Expense	-6.42	-1.54	1.68	-2.3	-36,672	-4,741.12	-5,058.82	42.75	-23.71
EBITDA-CapEx/Interest Expense	-6.72	-1.67	1.48	-4.11	-40,155	-5,072.41	-6,297.09	-6.34	-442.56
EBIT to Interest Expense	-6.61	-1.69	1.6	-2.48	-40,079	-5,361.29	-6,179.73	15.03	-497.79
Interest Expense	2	2	5	3	- -	- -	- -	1	- -
Common Equity/Total Assets	-520.55	-256.58	-43.59	-14.22	-20.27	-35.96	-48.16	-37.67	-38.76
Long-Term Debt/Equity (%)	- -	- -	22.66	- -	1.71	2.91	3.63	5.35	7.47
Long-Term Debt/Capital (%)	499.76	181.36	-71.25	- -	-8.21	-7.88	-6.99	-14.04	-18.77
Long-Term Debt/Total Assets (%)	179.25	109.35	16.11	- -	1.52	2.6	3.13	4.59	6.08
Total Debt/Equity (%)	-130.35	-243.3	29.52	- -	1.99	3.36	3.92	5.78	7.84
Total Debt/Capital (%)	528.15	181.36	-92.79	- -	-9.59	-9.09	-7.55	-15.16	-19.7
Total Debt/Total Assets (%)	189.43	109.35	20.98	- -	1.77	3	3.38	4.96	6.38
Net Debt to Equity	-121.86	-198.82	-86.62	-98.6	-80.06	-30.8	-25.26	-24.06	-22.65
Net Debt/Capital (%)	752.78	221.72	58.55	86.77	79.4	45.46	32.75	37.38	35.08
EBITDA	-11	-4	8	-6	-37	-81	-56	25	-2
EBITDA-CapEx	-11	-4	7	-11	-40	-86	-69	-4	-38
Operating Income (Loss)	-11	-4	7	-7	-40	-91	-68	9	-43

Liquidity (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.23	0.66	6.47	19.63	13.25	7.16	5.1	5.93	4.36
Current Ratio	1.28	2.69	7.63	20.58	14.21	8.09	6.2	7.29	5.26
Quick Ratio	1.12	2.46	7.42	20.24	13.94	7.81	5.9	6.97	4.99
CFO/Avg Current Liab	- -	-2.06	0.64	0.55	-0.83	-1.37	-0.13	1.34	1.09
Common Equity/Total Assets	-520.55	-256.58	-43.59	-14.22	-20.27	-35.96	-48.16	-37.67	-38.76
Long-Term Debt/Equity (%)	- -	- -	22.66	- -	1.71	2.91	3.63	5.35	7.47
Long-Term Debt/Capital (%)	499.76	181.36	-71.25	- -	-8.21	-7.88	-6.99	-14.04	-18.77
Long-Term Debt/Total Assets (%)	179.25	109.35	16.11	- -	1.52	2.6	3.13	4.59	6.08
Total Debt/Equity (%)	-130.35	-243.3	29.52	- -	1.99	3.36	3.92	5.78	7.84
Total Debt/Capital (%)	528.15	181.36	-92.79	- -	-9.59	-9.09	-7.55	-15.16	-19.7
Total Debt/Total Assets (%)	189.43	109.35	20.98	- -	1.77	3	3.38	4.96	6.38
CFO/Total Liabilities	-50.78	-37.86	20.26	41.74	-37.34	-86.46	-9.06	86.03	59.76
CFO/CapEx	-24.72	-44.39	7.49	2.08	-5.45	-7.4	-0.41	2.29	1.79
Altman's Z-Score	-9.41	-2.53	6.15	33.28	13.32	7.38	5.55	6.96	6.78

Working Capital (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	2.72	3.88	4.57	6.26	6.72	7.12	7.42	7.28
Days Sales Outstanding	- -	134.09	94.08	79.84	58.27	54.28	51.3	49.2	50.15
Inventory Turnover	- -	8.93	6.9	5.61	7.47	10.67	7.55	7.49	7.73
Days Inventory Outstanding	- -	40.88	52.9	65.09	48.88	34.21	48.37	48.73	47.25
Accounts Payable Turnover	- -	4.58	4.62	5.38	6.73	9.34	6.53	7.04	5.71
Accounts Payable Turnover Days	- -	79.77	78.95	67.82	54.24	39.1	55.93	51.88	63.9
Cash Conversion Cycle	- -	95.2	68.03	77.11	52.92	49.4	43.74	46.05	33.5
Inventory to Cash Days	- -	93.21	41.18	14.75	9.39	20.06	2.93	0.46	2.91
Inventories	- -	1	1	2	2	4	8	8	10
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	1	1	2	2	4	8	8	10

Enterprise Value (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	295	1,271	1,078	613	578	740	1,128
- Cash & Cash Equivalents	1	4	99	410	330	123	99	120	117
+ Preferred Equity and Hybrid Capital	36	46	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	19	24	25	- -	8	13	15	26	37
Enterprise Value	53	67	221	861	756	368	351	473	865
Total Capital	4	14	-27	-62	-86	-147	-203	-174	-187
Total Debt/Capital (%)	528.15	181.36	-92.79	- -	-9.59	-9.09	-7.55	-15.16	-19.7
Total Debt / EV	0.35	0.37	0.11	- -	0.01	0.04	0.04	0.06	0.04
EV/Sales	3.88	2.92	4.27	13.75	8.04	2.69	1.6	1.43	2.51
EV/EBITDA	- -	- -	28.79	- -	- -	- -	- -	19.19	- -
EV/EBIT	- -	- -	30.2	- -	- -	- -	- -	54.61	- -
EV/Cash Flow to Firm	- -	- -	19.2	68.78	- -	- -	- -	7.24	13.43
EV/Free Cash Flow to Firm	- -	- -	17.76	49.86	- -	- -	43.79	5.05	8.61
Diluted Market Cap	- -	- -	298	1,271	1,078	613	578	780	1,128
Diluted Enterprise Value	53	67	224	861	756	504	495	686	1,048
EV per Share	5.46	6.25	25.78	45.5	30.08	14.13	13.08	17.05	29.84
TTM Sales	14	23	52	63	94	137	220	332	344
TTM EBITDA	-11	-4	8	-6	-37	-81	-56	25	-2
TTM Operating Income	-11	-4	7	-7	-40	-91	-68	9	-43
TTM Cash Flow to Firm	-11	-10	12	13	-19	-42	-6	65	64
TTM Free Cash Flow to Firm	-10	-10	12	17	-15	-36	8	94	100

Multiples (USD)

API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	37.42	86.97	-69.52	-17.03	72.34	8.37	11.23
EV/EBIT	- -	- -	30.2	- -	- -	- -	- -	54.61	- -
Enterprise Value	53	67	221	861	756	368	351	473	865
Low Price	- -	- -	15.26	21.01	37.99	15.58	9.26	16.97	14.59
EV/Sales	3.88	2.92	4.27	13.75	8.04	2.69	1.6	1.43	2.51
EV/EBITDA	- -	- -	28.79	- -	- -	- -	- -	19.19	- -
Price/Earnings	- -	- -	94.53	- -	- -	- -	- -	40.57	- -
Price/Earnings Average	- -	- -	64.59	-75.22	-52.9	-11.22	-9.29	38.11	-28.78
Price/Earnings High	- -	- -	109.38	-144.29	-86.51	-18.78	-13.8	54.56	-50.61
Price/Earnings Low	- -	- -	41.97	-38.67	-30.52	-6.05	-4.32	25.83	-17.51
Price/Book Value	- -	- -	-5.65	-20.35	-11.5	-3.81	-2.65	-3.7	-5.03
Price/Book Value Average	- -	- -	-3.86	-12.38	-17.66	-4.68	-2.45	-3.48	-3.1
Price/Book Value High	- -	- -	-6.54	-23.75	-28.88	-7.84	-3.63	-4.98	-5.45
Price/Book Value Low	- -	- -	-2.51	-6.37	-10.19	-2.52	-1.14	-2.36	-1.89
Price/Tangible Book Value	- -	- -	3.47	3.06	3.34	2.25	2.11	2.12	3.04
Price/Tangible Book Value Average	- -	- -	2.37	1.86	5.13	2.76	1.95	1.99	1.87
Price/Tangible Book Value High	- -	- -	4.01	3.57	8.39	4.62	2.9	2.85	3.29
Price/Tangible Book Value Low	- -	- -	1.54	0.96	2.96	1.49	0.91	1.35	1.14
Price/Sales	- -	- -	5.69	20.29	11.45	4.48	2.63	2.23	3.28
Price/Sales Average	- -	- -	3.89	12.35	17.59	5.5	2.43	2.09	2.02
Price/Sales High	- -	- -	6.58	23.69	28.77	9.2	3.61	3	3.55
Price/Sales Low	- -	- -	2.53	6.35	10.15	2.96	1.13	1.42	1.23
Price/Cash Flow	- -	- -	42.06	128.85	-56.77	-14.72	-102.81	11.41	17.52
Price/Cash Flow Average	- -	- -	28.74	78.42	-87.2	-18.09	-94.93	10.72	10.81
Price/Cash Flow High	- -	- -	48.67	150.42	-142.6	-30.27	-140.97	15.35	19
Price/Cash Flow Low	- -	- -	18.67	40.31	-50.31	-9.74	-44.11	7.27	6.57
Price/Free Cash Flow Average	- -	- -	25.57	52.93	-106.79	-20.91	66.8	7.86	6.93
Price/Free Cash Flow High	- -	- -	43.3	101.52	-174.65	-35.01	99.2	11.25	12.18
Price/Free Cash Flow Low	- -	- -	16.61	27.21	-61.61	-11.27	31.04	5.33	4.21
EV/Sales Average	3.88	2.92	2.47	5.81	14.18	4.7	2.05	1.81	1.79
EV/Sales High	3.88	2.92	5.16	17.14	25.36	8.4	3.23	2.72	3.32
EV/Sales Low	3.88	2.92	1.1	- -	6.73	2.16	0.75	1.14	1
EV/EBITDA Average	-5.05	-18.93	16.64	-59.93	-36.37	-7.99	-8.1	24.41	-301.84
EV/EBITDA High	-5.05	-18.93	34.82	-176.93	-65.05	-14.29	-12.75	36.57	-560.48
EV/EBITDA Low	-5.05	-18.93	7.45	2	-17.28	-3.68	-2.96	15.32	-168.26
EV/EBIT Average	-4.9	-17.34	17.45	-55.6	-33.28	-7.06	-6.63	69.44	-14.38
EV/EBIT High	-4.9	-17.34	36.53	-164.17	-59.52	-12.63	-10.44	104.05	-26.7
EV/EBIT Low	-4.9	-17.34	7.82	1.86	-15.81	-3.25	-2.42	43.6	-8.01
Last Price	- -	- -	34.37	67.15	42.87	23.54	21.58	26.65	38.9
High Price	- -	- -	39.77	78.39	107.69	48.4	29.59	35.84	42.18
Enterprise Value Average	53	67	128	364	1,334	644	451	602	615
Enterprise Value High	53	67	268	1,074	2,386	1,151	710	902	1,143
Enterprise Value Low	53	67	57	-12	634	296	165	378	343

Shares Outstanding	15	15	17	25	25	27	27	28	30
Diluted Weighted Avg Shares	10	11	9	19	25	26	27	29	29
Basic Weighted Avg Shares	10	11	9	19	25	26	27	28	29
Revenue per Share	1.41	2.14	6.04	3.31	3.74	5.26	8.2	11.96	11.88
EBITDA per Share	-1.08	-0.33	0.9	-0.32	-1.46	-3.09	-2.08	0.89	-0.07
Operating Income per Share	-1.11	-0.36	0.85	-0.35	-1.59	-3.5	-2.54	0.31	-1.48
Basic EPS, GAAP	-1.56	-0.93	0.36	-0.54	-1.24	-2.58	-2.14	0.66	-0.83
Basic EPS from Cont Ops	-1.26	-0.6	0.61	-0.54	-1.24	-2.58	-2.14	0.66	-0.83
Diluted EPS, GAAP	-1.56	-0.93	0.36	-0.54	-1.24	-2.58	-2.14	0.62	-0.83
Diluted EPS from Cont Ops	-1.26	-0.6	0.61	-0.54	-1.24	-2.58	-2.14	0.62	-0.83
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.25	-1.15	0.82	0.52	-0.76	-1.6	-0.21	2.34	2.22
Free Cash Flow per Basic Share	-1.3	-1.18	0.71	0.27	-0.89	-1.81	-0.72	1.32	0.98
Cash & Equivalents per Share	0.12	0.42	11.52	21.65	13.11	9.93	9.07	10.55	10.33
Book Value per Share	-5.22	-5.4	-6.08	-3.3	-3.73	-6.17	-8.15	-7.2	-7.74
Tangible Book Value per Share	-5.15	-5.31	9.92	21.96	12.84	10.47	10.22	12.59	12.81

Castle Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)